Call for Abstract
3rd International Conference on Retroviruses and Novel Drugs, will be organized around the theme “Novel therapy and innovations for treatment of retroviruses”
Retroviruses 2017 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Retroviruses 2017
Submit your abstract to any of the mentioned tracks.
Register now for the conference by choosing an appropriate package suitable to you.
A retrovirus is a single-stranded positive-sense RNA virus with a DNA intermediate and, as an obligate parasite, targets a host cell. Retroviruses have integrated their own genome into the germ line, their genome is passed retroviruses have integrated their own genome into the germ line, their genome is passed on to a on to an exogenous and endogenous retrovirus. Also immunology-related pathologies, such as autoimmune diseases like multiple sclerosis.
- Track 1-1Types of Endogenous and Exogenous Retroviruses
- Track 1-2Human Immunodeficiency Viruses
- Track 1-3Liver Retroviral Diseases
- Track 1-4Retroviral Autoimmune Diseases
- Track 1-5Pregnancy Retroviral Disease
- Track 1-6Causes of Retroviral Diseases
- Track 1-7Animals Retrovirus Diseases
- Track 1-8Nervous System Retroviral Diseases
- Track 1-9Cats Retroviral Diseases
- Track 1-10Humans Retroviral Diseases
Antiretroviral drugs are medications for the treatment of infection by retroviruses, primarily HIV. Different classes of antiretroviral drugs act on different stages of the HIV life cycle. Combination of several (typically three or four) antiretroviral drugs is known as highly active anti-retroviral therapy.
- Track 2-1Antiretroviral Treatment
- Track 2-2CD4 count test
- Track 2-3Viral Load Measurement
The care of the human immunodeficiency virus (HIV) infected patient has changed dramatically in the last few years. Potent new antiretroviral drugs combined with updated treatment strategies have now achieved efficient inhibition of HIV replication in most patients. It is clear that the eradication of HIV is not achievable with existing anti-HIV drugs and in spite of the major advances there remain many challenges in the clinical management of HIV-infected individuals.
- Track 3-1New Antiretroviral Agents
- Track 3-2Antiretroviral Therapy of Treatment-Naive Individuals
- Track 3-3Pharmacokinetic Interactions of ART Agents
- Track 3-4Effective Postexposure Treatment of Retrovirus
- Track 3-5Gene therapy with cultured skin grafts
- Track 3-6Garlic Supplements Can Impede HIV Medication
- Track 3-7A Mantram Studied in Adults With HIV
Retroviruses are an efficient means to deliver single DNA expression constructs to a wide range of mammalian cell types. They are by far the easiest and fastest means to deliver genes stably to mammalian cells. They have an additional advantage in that systems developed application to deliver large libraries of genes or peptides to target cells.
- Track 4-1Viral and nonviral delivery systems for gene delivery
- Track 4-2Polymeric Gene Delivery
- Track 4-3Viral vectors delivery systems
- Track 4-4synthetic particulate delivery systems
- Track 4-5protein vaccine delivery systems
Acute HIV infection and primary HIV infection both describe the period immediately after infection when the patient is viremic and has detectable HIV RNA without diagnostic HIV antibodies. Early infection refers to both acute and recent infection, after which infection is defined as chronic.
- Track 5-1Acute Retroviral Syndrome
- Track 5-21p36 Deletion Syndrome
- Track 5-3Retrovirus HDTV and Neuropathy
- Track 5-4Retrovirus HTLV-1
- Track 5-5Retroviruses Life cycle
- Track 5-6Retrovirus skin lesions
- Track 5-7Retroviruses Biology
- Track 5-8Retroviruses VS Lentivirus
- Track 5-9Retrovirus Characteristics
- Track 5-10Molecular Retrovirology
- Track 5-11AIDS and Opportunistic Infections
- Track 5-12AIDS and Neuropathy
- Track 5-13AIDS and Condom
- Track 5-14AIDS and Medicine
- Track 5-15AIDS and Poverty
- Track 5-16AIDS and Xerostonics
- Track 5-17AIDS and Prostitutions
Endogenous viral elements in the genome that closely resemble and can be derived from retroviruses and exogenous retroviruses such as human immunodeficiency virus (HIV) and human T cell leukaemia virus.
- Track 6-1Endogenous retroviruses
- Track 6-2Exogenous Retroviruses
- Track 6-3Endogenous retrovirus evolution
- Track 6-4Endogenous retrovirus vampire
Osteoporosis is a disease that causes bones to become weak and easy to break. Osteoporosis increases the risk of fractures of the hip, spine, and wrist. Factors that may increase the risk of osteoporosis in people living with HIV include HIV infection itself and some HIV medicines.
- Track 7-1Pathogenesis of Osteoporosis
- Track 7-2HIV and osteoporosis
HIV/AIDS normally includes the use of multiple antiretroviral drugs in an attempt to control HIV infection. There are several classes of antiretroviral agents that act on different stages of the HIV life-cycle. The use of multiple drugs that act on different viral targets is known as highly active antiretroviral therapy.
- Track 8-1AntiRetroviral Drugs for HIV
- Track 8-2AntiRetroviral Drugs and Alcohol
- Track 8-3AntiRetroviral Drugs Dosages
- Track 8-4AntiRetroviral Drugs Interactions
- Track 8-5AntiRetroviral Drugs Side effects
- Track 8-6AntiRetroviral Drugs Adverse Effects
A retrovirus vector is an infectious virus used to introduce a nonviral gene into mitotic cells in vivo or in vitro. Transduction does not require physical contact between the cell donating the DNA and the cell receiving the DNA and it is DNase resistant. Transduction is a common tool used by molecular biologists to stably introduce a foreign gene into a host cell's genome.
- Track 9-1Retrovirus Transduction System
- Track 9-2Retroviral-Mediated Gene Transduction
- Track 9-3Retroviral Transduction of T-cell Receptors
- Track 9-4Nucleic Acid Delivery
- Track 9-5Retroviral transfection
- Track 9-6Retrovirus Genome Organization
- Track 9-7Retroviral Genome Replication
- Track 9-8Retrovirus Integration into Host Genome
- Track 9-9Retroviral Vectors
- Track 9-10Retrovirus Genome gag pol env
- Track 9-11Retrovirus Genome & Proteome
- Track 9-12Retrotransposons
- Track 9-13Retrovirus vs Adenovirus Gene Therapy
- Track 9-14Retrovirus Gene Therapy
- Track 9-15Retroviral Gene Transfer Techniques
HIV is one of the best-known retroviruses. Oncogenic retroviruses are cancer-causing viruses. Numerous oncoretroviruses are associated with animal diseases. In humans, two retroviruses, called HTLV and XMRV, have been associated with a type of leukemia and with prostate cancer.
- Track 10-1Oncovirus
- Track 10-2Retrovirus cancer
- Track 10-3Prostate cancer
- Track 10-4Retroviral Pathogenesis of Cancer
- Track 10-5Retroviral Cancer Gene Theraphy
- Track 10-6Retroviral Transduction Cancer
- Track 10-7Retroviruses Cancer Treatment
- Track 10-8Retroviral Proto oncogenesis
- Track 10-9Retrovirus Breast Cancer
Some infectious diseases can be passed from person to person. Signs and symptoms vary depending on the organism causing the infection. Human Papilloma Virus is the most common sexually transmitted diseases. Some types of these viruses can cause genital warts and cancers. Genital warts usually appear as a small bump or group of bumps in the genital area. However, if the infection is High risk, then there will be more chances of occurrence of cervical cancer. Vaccination is recommended for the patients with compromised immune system.
- Track 11-1TB/HIV Co-Infection
- Track 11-2Leishmania/HIV co-infections
- Track 11-3HTLV-1/-2 and HIV-1 co-infections
- Track 11-4HIV–HCV co-infections
- Track 11-5HCV and HBV co-infections
- Track 11-6Hepatitis B and Syphilis Co-Infection
- Track 11-7HIV/AIDS Epidemology
Antiretroviral therapy has been exceeding by adapting the various novel drug delivery methods, which pays pathway for many scientists to prove the efficiency of their techniques. The formulation design and optimization of analytical techniques requires multidisciplinary research for ultimate marketing of these NDDS products especially for ARV drugs, because of the intricacy of the viral infections diseases. Certainly, the present techniques with new therapeutic agents and scheduled regimens can provide notice able improvement in the future of HIV virus infected people’s living.
- Track 12-1Novel drugs and current therapeutic approaches
- Track 12-2 Discovery Approaches
- Track 12-3Therapeutic approaches
- Track 12-4Novel drug therapies
- Track 12-5ART Drug Discoveries
- Track 12-6Retrovirology Market Analysis
- Track 12-7International Funding on Antiretroviral drugs
- Track 12-8Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTI)
- Track 12-9Highly Active Anti-Retroviral therapy (HAART)
- Track 12-10Retroviral Approaches to Gene Therapy of Cystic Fibrosis
- Track 12-11Retroviral Gene Therapy in Vaccine Development
- Track 12-12Human Retroviral Research
- Track 12-13Advances in Sexually Transmitted Diseases